Topoisomerase II alpha (TOP2A), highly expressed in various human cancers, is a potential prognostic and predictive marker as well as a therapeutic target in combating HCC (Panvichian et al., 2015; Wang et al., 2022). This evidence concerns the gene TOP2A and cancer.